Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
NCT00496821
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG:
ALN-RSV01
Sponsor
Alnylam Pharmaceuticals